Barclays downgraded shares of Moderna (NASDAQ:MRNA – Free Report) from an overweight rating to an equal weight rating in a report published on Tuesday, Ratings reports. The firm currently has $45.00 ...

In a report released on February 14, Luca Issi from RBC Capital maintained a Hold rating on Moderna (MRNA – Research Report), with a price ...

EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...

CSL and Cochlear are two of Australia’s blue-chip healthcare stocks, stalwarts of many investors portfolios, whereas Pro ...

Goldman Sachs said that the “reciprocal tariff” plan is expected to impact India in three ways. (Photo source: PTI) With US President Donald Trump announcing that the country will likely ...

Goldman Sachs analyst Matt Greene maintained a Buy rating on Glencore (GLEN – Research Report) today and set a price target of £5.00. The ...

Goldman Sachs has appointed insiders William Connolly and Michael Voris as co-heads of Equity Capital Markets (ECM) in the ...

He said that hedge fund ownership of potential deregulation beneficiaries, stocks with small business exposure, and domestic ...

Goldman Sachs raises its year-end gold (GC=F) price target to $3,100 from $2,890. Yahoo Finance senior business reporter Ines Ferré outlines what's fueling the bullish call on the commodity.

Feb 19 (Reuters) - Goldman Sachs (GS.N), opens new tab has appointed insiders William Connolly and Michael Voris as co-heads of Equity Capital Markets (ECM) in the Americas, according to a memo ...

Learn More The gold price rose to a new record above US$2,940 per ounce last week, and top broker Goldman Sachs reckons this safe-haven asset has more room to run this year. The Australian ...